Are Zydus Wellness Ltd latest results good or bad?

May 19 2026 07:19 PM IST
share
Share Via
Zydus Wellness Ltd's latest results show strong revenue growth with net sales up 62.60% year-on-year, but net profit declined 5.76% compared to last year, raising concerns about operational efficiency and rising costs. While the company has recovered from a previous loss, ongoing margin compression and increased interest expenses suggest challenges ahead for sustainable profitability.
Zydus Wellness Ltd's latest financial results for the quarter ended March 2026 present a mixed picture. The company reported a significant increase in net sales, reaching ₹1,484.70 crores, which reflects a robust sequential growth of 53.87% and a year-on-year growth of 62.60%. This marks the highest quarterly revenue achieved by the company, driven by strong demand across its wellness product portfolio.
However, despite this impressive revenue growth, the net profit for the quarter was ₹162.00 crores, which represents a substantial recovery from a loss of ₹39.90 crores in the previous quarter. Yet, it also indicates a decline of 5.76% compared to the same quarter last year. This juxtaposition raises concerns regarding the company's operational efficiency and cost management, particularly as operating margins have contracted to 18.30% from 20.87% a year earlier, highlighting pressures from rising input costs. Moreover, the company's profitability metrics reveal challenges, with a significant increase in interest expenses, which surged to ₹38.70 crores from just ₹4.20 crores a year ago. This dramatic rise in interest costs, coupled with a low tax rate of 8.63%, suggests that the recovery in profitability may not be as strong as the headline figures imply. In terms of operational performance, the company generated an operating profit of ₹270.10 crores, which indicates a strong sequential improvement. However, the overall financial picture is complicated by the volatility in profitability observed in previous quarters, with the half-yearly performance showing a PAT margin of only 4.98% for H2 FY26. The company has seen an adjustment in its evaluation, reflecting the complexities in its financial performance. While Zydus Wellness has demonstrated strong revenue growth, the persistent margin compression and rising costs present significant challenges that need to be addressed for sustainable profitability moving forward. Investors should closely monitor the company's ability to manage these operational challenges in the upcoming quarters.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News